Elmira Yelshibayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elmira Yelshibayeva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Tairkhan Dautov
University Medical Center
3 shared publications - D. Mardenkyzy
Medical Center Hospital of the Presidential Office of the Republic of Kazakhstan
2 shared publications - Raushan Rakhimzhanova
Radiology Department named after academic Zh.Kh. Khamzabayev, Astana Medical University, Astana, Kazakhstan
2 shared publications - A. B. Mergalimova
Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
1 shared publication - A. N. Sapkina
Medical Center Hospital of the Presidential Office of the Republic of Kazakhstan
1 shared publication - A. Zh. Suigenbayev
Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
1 shared publication
Latest Publications
- Open Access
Computed Tomography in the Evaluation and Identification of Features of Coronary Atherosclerosis Between European and Asian Populations in Kazakhstan
Background and Objectives: This study aimed to compare coronary plaque characteristics between Asian and European populations undergoing coronary CT angiography and to examine associations between cardiovascular risk factors and coronary artery calcification. Materials and Methods: In this retrospective, two-center, cross-sectional observational study, 1591 adult patients (1203 of Asian and 388 of European descent) referred for coronary computed tomography angiography (CCTA) due to suspected coronary artery disease between 2008 and 2025 were included. Demographic, clinical characteristics, and laboratory data were obtained from medical records. Computed tomography (CT) was performed on different CT scanners, including a 64-slice Siemens SOMATOM Definition AS, a 250-slice Siemens SOMATOM, a 640-slice multi-detector Canon Aquilion ONE, and a 128-slice multi-detector GE Revolution scanner with prospective cardiac synchronization and 0.6 mm slice reconstruction. Coronary artery calcium (CAC) scores were quantified using automated software “Vitrea”. Associations between ethnicity, cardiovascular risk factors, and CAC were assessed using non-parametric analyses and multivariable regression models. Stata 18 software was used for all statistical analyses. Results: European participants demonstrated a higher prevalence of obesity, hypertension, tobacco use, and alcohol consumption compared with Asian participants. The prevalence of CAC > 0 was higher in Europeans than in Asians (60.6% vs. 50.3%, p < 0.01). European individuals were independently associated with CAC presence in multivariable analysis. Multivessel (≥2-vessel) stenosis and calcified plaques were more frequently observed in Europeans, whereas non-calcified and low-density plaques predominated among Asians. Conclusions: Within this referral-based cohort, differences in coronary plaque characteristics were observed between the studied groups within this clinical CCTA cohort. The European group was associated with a higher prevalence of calcified plaques, whereas non-calcified and low-density plaques were more frequently observed among Asian participants. These findings show associations between ethnicity and plaque characteristics within a clinical cohort and require confirmation in prospective studies.
Open AccessComputed Tomography in the Evaluation and Identification of Features of Coronary Atherosclerosis Between European and Asian Populations in Kazakhstan
Background and Objectives: This study aimed to compare coronary plaque characteristics between Asian and European populations undergoing coronary CT angiography and to examine associations between cardiovascular risk factors and coronary artery calcification. Materials and Methods: In this retrospective, two-center, cross-sectional observational study, 1591 adult patients (1203 of Asian and 388 of European descent) referred for coronary computed tomography angiography (CCTA) due to suspected coronary artery disease between 2008 and 2025 were included. Demographic, clinical characteristics, and laboratory data were obtained from medical records. Computed tomography (CT) was performed on different CT scanners, including a 64-slice Siemens SOMATOM Definition AS, a 250-slice Siemens SOMATOM, a 640-slice multi-detector Canon Aquilion ONE, and a 128-slice multi-detector GE Revolution scanner with prospective cardiac synchronization and 0.6 mm slice reconstruction. Coronary artery calcium (CAC) scores were quantified using automated software “Vitrea”. Associations between ethnicity, cardiovascular risk factors, and CAC were assessed using non-parametric analyses and multivariable regression models. Stata 18 software was used for all statistical analyses. Results: European participants demonstrated a higher prevalence of obesity, hypertension, tobacco use, and alcohol consumption compared with Asian participants. The prevalence of CAC > 0 was higher in Europeans than in Asians (60.6% vs. 50.3%, p < 0.01). European individuals were independently associated with CAC presence in multivariable analysis. Multivessel (≥2-vessel) stenosis and calcified plaques were more frequently observed in Europeans, whereas non-calcified and low-density plaques predominated among Asians. Conclusions: Within this referral-based cohort, differences in coronary plaque characteristics were observed between the studied groups within this clinical CCTA cohort. The European group was associated with a higher prevalence of calcified plaques, whereas non-calcified and low-density plaques were more frequently observed among Asian participants. These findings show associations between ethnicity and plaque characteristics within a clinical cohort and require confirmation in prospective studies.
- Open Access
- 25 July 2025
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (6) , 314-324
Levamisole-induced leukoencephalopathy: a rare drug side effect
Levamisole is an antihelminthic drug that is widely used in clinical practice. One of its rare side effects is the development of levamisole-associated multifocal inflammatory leukoencephalopathy, which progresses 2–8 weeks after treatment and is characterized by brain demyelination and white matter damage. The article describes a case of levamisole-induced leukoencephalopathy, which should be differentiated from multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica.
- 25 July 2025
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (6) , 314-324
Open AccessLevamisole-induced leukoencephalopathy: a rare drug side effect
Levamisole is an antihelminthic drug that is widely used in clinical practice. One of its rare side effects is the development of levamisole-associated multifocal inflammatory leukoencephalopathy, which progresses 2–8 weeks after treatment and is characterized by brain demyelination and white matter damage. The article describes a case of levamisole-induced leukoencephalopathy, which should be differentiated from multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica.
- Open Access
- 27 October 2022
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 103 (4-6) , 94-100
Histologycally Confirmed Synchronous Pancreatic and Duodenal Double Cancer
Pancreatic adenocarcinoma is the most pervasive form of cancer with high mortality rates. Being obscure at the early stages, non-specific symptoms and their onset only in the late stages of the disease lead to detection of the III–IV stages cancer on initial diagnistics. Gastrointestinal stromal tumor (GIST) is an intramucosal tumor of gastrointestinal tract, which is a derivate of interstitial cells of Cajal. The unicity of the presented clinical case is the rareness of GIST, which was an incidental finding during diagnostics of pancreatic adenocarcinoma. Diagnosed by intravenous contrast computed tomography, synchronous pancreatic and duodenal double cancer was confirmed histologically after Whipple surgery. The opportunities of intravenous contrast computed tomography in diagnostics of synchronous cancer were demonstrated.
- 27 October 2022
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 103 (4-6) , 94-100
Open AccessHistologycally Confirmed Synchronous Pancreatic and Duodenal Double Cancer
Pancreatic adenocarcinoma is the most pervasive form of cancer with high mortality rates. Being obscure at the early stages, non-specific symptoms and their onset only in the late stages of the disease lead to detection of the III–IV stages cancer on initial diagnistics. Gastrointestinal stromal tumor (GIST) is an intramucosal tumor of gastrointestinal tract, which is a derivate of interstitial cells of Cajal. The unicity of the presented clinical case is the rareness of GIST, which was an incidental finding during diagnostics of pancreatic adenocarcinoma. Diagnosed by intravenous contrast computed tomography, synchronous pancreatic and duodenal double cancer was confirmed histologically after Whipple surgery. The opportunities of intravenous contrast computed tomography in diagnostics of synchronous cancer were demonstrated.
- Open Access
- 19 October 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (3) , 51-57
CТ densitometry as an additional method in the diagnosis of pulmonary hypertension: a prospective study
INTRODUCTION: This article presents the results of application of CT densitometry in the computed tomography (CT) of the chest to diagnose various forms of pulmonary hypertension.OBJECTIVES: To determine the diagnostic value of CT densitometry using comparative analysis of lung tissue density in patients with various forms of pulmonary hypertension.MATERIALS AND METHODS: The study included 528 patients diagnosed with pulmonary hypertension by means of right heart catheterization (RHC) of the National Research Cardiac Surgery Center, Republic of Kazakhstan. All patients were divided into 4 groups according to the classification of pulmonary hypertension of the World Health Organization (ESC/ERS Guidelines) from 2015. The first group included 254 patients with pulmonary hypertension pulmonary hypertension due to left heart disease (PHLHD). The second group included 210 patients with pulmonary arterial hypertension (PAH). The third group included 49 patients with chronic thromboembolic pulmonary hypertension (CTEPH). The fourth group — 15 patients with pulmonary hypertension due to respiratory disease (PHDRD). The mean age of the patients was 52.15±16.75 years. Contrast-enhanced chest CT imaging performed with a 64-slice multislice computed tomography system (Somatom Definition AS, Siemens) with post-processing to assess the lung tissue densitometric parameters, analyse the diameters of the pulmonary trunk and its main branches. The CT examination was carried in accordance with an «Embolism» protocol with intravenous administration of a contrast agent according to indications. Statistics: analysis was conducted using the Statistica 10 software. To quantitatively compare the two groups nonparametric Mann-Whitney test and the Kruskal-Wallace test were applied. Mean value and standard deviation in the format of «M±S» were used for quantitative parameters. Correlation analysis was carried out using Spearman’s nonparametric rank correlation.RESULTS: In patients with severe pulmonary hypertension a tendency for fibrotic changes was most clearly observed in cases of pulmonary hypertension due to left heart disease (–809.92±26.52), and emphysematous changes in the pulmonary arterial hypertension group (–843.27±43.88).CONCLUSION: CT lung densitometry should be performed in all patients with suspected pulmonary hypertension as an additional method of examination.
- 19 October 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (3) , 51-57
Open AccessCТ densitometry as an additional method in the diagnosis of pulmonary hypertension: a prospective study
INTRODUCTION: This article presents the results of application of CT densitometry in the computed tomography (CT) of the chest to diagnose various forms of pulmonary hypertension.OBJECTIVES: To determine the diagnostic value of CT densitometry using comparative analysis of lung tissue density in patients with various forms of pulmonary hypertension.MATERIALS AND METHODS: The study included 528 patients diagnosed with pulmonary hypertension by means of right heart catheterization (RHC) of the National Research Cardiac Surgery Center, Republic of Kazakhstan. All patients were divided into 4 groups according to the classification of pulmonary hypertension of the World Health Organization (ESC/ERS Guidelines) from 2015. The first group included 254 patients with pulmonary hypertension pulmonary hypertension due to left heart disease (PHLHD). The second group included 210 patients with pulmonary arterial hypertension (PAH). The third group included 49 patients with chronic thromboembolic pulmonary hypertension (CTEPH). The fourth group — 15 patients with pulmonary hypertension due to respiratory disease (PHDRD). The mean age of the patients was 52.15±16.75 years. Contrast-enhanced chest CT imaging performed with a 64-slice multislice computed tomography system (Somatom Definition AS, Siemens) with post-processing to assess the lung tissue densitometric parameters, analyse the diameters of the pulmonary trunk and its main branches. The CT examination was carried in accordance with an «Embolism» protocol with intravenous administration of a contrast agent according to indications. Statistics: analysis was conducted using the Statistica 10 software. To quantitatively compare the two groups nonparametric Mann-Whitney test and the Kruskal-Wallace test were applied. Mean value and standard deviation in the format of «M±S» were used for quantitative parameters. Correlation analysis was carried out using Spearman’s nonparametric rank correlation.RESULTS: In patients with severe pulmonary hypertension a tendency for fibrotic changes was most clearly observed in cases of pulmonary hypertension due to left heart disease (–809.92±26.52), and emphysematous changes in the pulmonary arterial hypertension group (–843.27±43.88).CONCLUSION: CT lung densitometry should be performed in all patients with suspected pulmonary hypertension as an additional method of examination.
- 15 October 2020
- Published by National Academy of Sciences of the Republic of Kazakshtan in Reports of the NAS RK
- Vol. 5 (333) , 94-102
COMPLEX ASSESSMENT OF COMPUTED TOMOGRAPHY OF THE LUNGS AND CLINICAL DATA IN COVID-19 PATIENTS, HOSPITALIZED IN THE CLINIC IN NUR-SULTAN
The ambiguity of the X-ray picture and clinic in patients with coronavirus infection (CVI) was the reason for this analysis in order to avoid diagnostic errors and to achieve the effect of the treatment. Conducted a comparative description of three clinical cases of patients with coronavirus infection COVID-19. All three patients differed in different parameters of SARS Co-2 PCR. In the first two patients who underwent CT on the 7th and 10th days from the onset of the disease on control CT after treatment, a regressive positive dynamics was observed; in the third patient, after an early CT scan on the second day of illness and on the next CT scan performed on the 10th day after the appearance of the clinic and a positive PCR test, progression of signs of viral pneumonia was observed with an increase in the affected area. Thus, the earlier CT was performed, the less pronounced the changes in the CT picture (the lesion volume is up to 5% or no changes are detected). When performing CT scan, patients with a long-term clinic (7-10 days from the onset of the disease) showed a characteristic picture of lung damage - up to 25-30%. The analysis of CT scans performed in the described clinical cases at different times from the onset of the disease, regardless of the results of PCR, confirms the need for CT scans 5-7 days after the first clinical signs appear. Also, as a result of our work, we once again received confirmation from numerous studies conducted in the world on the absence of a correlation between SARS Co-2 PCR and CT data.
- 15 October 2020
- Published by National Academy of Sciences of the Republic of Kazakshtan in Reports of the NAS RK
- Vol. 5 (333) , 94-102
COMPLEX ASSESSMENT OF COMPUTED TOMOGRAPHY OF THE LUNGS AND CLINICAL DATA IN COVID-19 PATIENTS, HOSPITALIZED IN THE CLINIC IN NUR-SULTAN
The ambiguity of the X-ray picture and clinic in patients with coronavirus infection (CVI) was the reason for this analysis in order to avoid diagnostic errors and to achieve the effect of the treatment. Conducted a comparative description of three clinical cases of patients with coronavirus infection COVID-19. All three patients differed in different parameters of SARS Co-2 PCR. In the first two patients who underwent CT on the 7th and 10th days from the onset of the disease on control CT after treatment, a regressive positive dynamics was observed; in the third patient, after an early CT scan on the second day of illness and on the next CT scan performed on the 10th day after the appearance of the clinic and a positive PCR test, progression of signs of viral pneumonia was observed with an increase in the affected area. Thus, the earlier CT was performed, the less pronounced the changes in the CT picture (the lesion volume is up to 5% or no changes are detected). When performing CT scan, patients with a long-term clinic (7-10 days from the onset of the disease) showed a characteristic picture of lung damage - up to 25-30%. The analysis of CT scans performed in the described clinical cases at different times from the onset of the disease, regardless of the results of PCR, confirms the need for CT scans 5-7 days after the first clinical signs appear. Also, as a result of our work, we once again received confirmation from numerous studies conducted in the world on the absence of a correlation between SARS Co-2 PCR and CT data.